IBT Bioservices is the contract research division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a strong client-oriented research and development service focused on our area of expertise, infectious diseases. The team at IBT Bioservices has extensive experience in antiviral and antibacterial screening and model development.
Gary Nabors, PhD
Gary heads IBT’s product development team to translate its discovery pipeline into practical solutions for infectious diseases.
Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.
Hong leads IBT’s assay development, quality control testing and provides logistical support for IBT’s research and bioservice projects. See Hong’s publications.
Aru Venkatasubrananiam, PhD
Aru leads IBT’s Chemistry Manufacturing Controls activities in vaccine formulation, development of analytics and animal potency models. See Aru’s publications.
Haimi leads IBT Bioservices’ strategic growth, marketing, and customer management team.